Search Results 311-320 of 19658 for alzheimers
It is the most potent genetic risk factor for Alzheimer's identified in the past 20 years. ... Alzheimer's disease patients than in a control group of 1,107 ...
While we know Alzheimer's is a disease of aging, there are other factors that increase our risk for this condition. As the prevalence of Alzheimer's rises ...
Clinical Trials · A Study to Evaluate Caregiver Connections via Technology for Patients with Alzheimer's and Other Types of Dementia · More about research at Mayo ...
Mayo Clinic Minute: Do Active Minds Delay Alzheimer's? Vivien Williams. March ... Active Mind may Delay Alzheimer's Symptoms, but not Underlying Disease featured ...
Watch Mayo Clinic neurologist Ronald C. Petersen, M.D., Ph.D., talk about mild cognitive impairment on HBO — The Alzheimer's Project. Research Profiles. Edit ...
Director, Alzheimer's Disease Research Center, 1992-2025. Distinguished Investigator Award, 2011. Member, World Dementia Council, 2014-2017. Chair, Advisory ...
Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer's Disease Research Center, discusses what people should know about the new drug.
Colleagues and other Alzheimer's researchers say his team's contributions to Alzheimer's research rank among the most significant in the field. “We are very ...
Learn whether drugs to treat Alzheimer's disease like lecanemab (Leqembi), available at the Alzheimer's Disease Treatment Clinic, might benefit you.
"When activated, human innate immunity results in inflammation, and previous research on this response to development of Alzheimer's disease has been ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Last chance! Your gift today has 5X the power to fuel medical progress using AI.